Pereiro X, Ruzafa N, Azkargorta M, Elortza F, Acera A, Ambrosio A
Cell Biosci. 2024; 14(1):5.
PMID: 38183095
PMC: 10770903.
DOI: 10.1186/s13578-023-01186-1.
Furukawa T, Kimura H, Sasaki M, Yamada T, Iwasawa T, Yagi Y
ACS Omega. 2023; 8(7):7030-7035.
PMID: 36844571
PMC: 9948553.
DOI: 10.1021/acsomega.2c07849.
Furukawa T, Kimura H, Torimoto H, Yagi Y, Kawashima H, Arimitsu K
ACS Med Chem Lett. 2021; 12(8):1238-1244.
PMID: 34413953
PMC: 8365995.
DOI: 10.1021/acsmedchemlett.1c00030.
Tanaka T, Yamada H, Kuroki M, Kodama S, Tamura K, Takamatsu Y
Transl Oncol. 2017; 10(4):476-484.
PMID: 28505517
PMC: 5430157.
DOI: 10.1016/j.tranon.2017.04.001.
Sedgwick A, DSouza-Schorey C
Cancers (Basel). 2016; 8(9).
PMID: 27589803
PMC: 5040982.
DOI: 10.3390/cancers8090080.
Endothelial-Specific EphA4 Negatively Regulates Native Pial Collateral Formation and Re-Perfusion following Hindlimb Ischemia.
Okyere B, Giridhar K, Hazy A, Chen M, Keimig D, Bielitz R
PLoS One. 2016; 11(7):e0159930.
PMID: 27467069
PMC: 4965112.
DOI: 10.1371/journal.pone.0159930.
Design and Characterization of Novel EphA2 Agonists for Targeted Delivery of Chemotherapy to Cancer Cells.
Wu B, Wang S, K DE S, Barile E, Quinn B, Zharkikh I
Chem Biol. 2015; 22(7):876-887.
PMID: 26165155
PMC: 4515144.
DOI: 10.1016/j.chembiol.2015.06.011.
In PC3 prostate cancer cells ephrin receptors crosstalk to β1-integrins to strengthen adhesion to collagen type I.
Yu M, Wang J, Muller D, Helenius J
Sci Rep. 2015; 5:8206.
PMID: 25644492
PMC: 4314628.
DOI: 10.1038/srep08206.
Mapping arealisation of the visual cortex of non-primate species: lessons for development and evolution.
Homman-Ludiye J, Bourne J
Front Neural Circuits. 2014; 8:79.
PMID: 25071460
PMC: 4081835.
DOI: 10.3389/fncir.2014.00079.
Synthesis and structure-activity relationships of amino acid conjugates of cholanic acid as antagonists of the EphA2 receptor.
Russo S, Incerti M, Tognolini M, Castelli R, Pala D, Hassan-Mohamed I
Molecules. 2013; 18(10):13043-60.
PMID: 24152675
PMC: 6270184.
DOI: 10.3390/molecules181013043.
Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor.
Incerti M, Tognolini M, Russo S, Pala D, Giorgio C, Hassan-Mohamed I
J Med Chem. 2013; 56(7):2936-47.
PMID: 23489211
PMC: 3953198.
DOI: 10.1021/jm301890k.
Hypoxia-induced alternative splicing in endothelial cells.
Weigand J, Boeckel J, Gellert P, Dimmeler S
PLoS One. 2012; 7(8):e42697.
PMID: 22876330
PMC: 3411717.
DOI: 10.1371/journal.pone.0042697.
EphrinA1 is released in three forms from cancer cells by matrix metalloproteases.
Beauchamp A, Lively M, Mintz A, Gibo D, Wykosky J, Debinski W
Mol Cell Biol. 2012; 32(16):3253-64.
PMID: 22688511
PMC: 3434542.
DOI: 10.1128/MCB.06791-11.
Structure-activity relationships and mechanism of action of Eph-ephrin antagonists: interaction of cholanic acid with the EphA2 receptor.
Tognolini M, Incerti M, Hassan-Mohamed I, Giorgio C, Russo S, Bruni R
ChemMedChem. 2012; 7(6):1071-83.
PMID: 22529030
PMC: 3677030.
DOI: 10.1002/cmdc.201200102.
Ephs and ephrins in cancer: ephrin-A1 signalling.
Beauchamp A, Debinski W
Semin Cell Dev Biol. 2011; 23(1):109-15.
PMID: 22040911
PMC: 3288643.
DOI: 10.1016/j.semcdb.2011.10.019.
Eph-A2 and Eph-A4 expression in human benign and malignant thyroid lesions: an immunohistochemical study.
Karidis N, Giaginis C, Tsourouflis G, Alexandrou P, Delladetsima I, Theocharis S
Med Sci Monit. 2011; 17(9):BR257-65.
PMID: 21873938
PMC: 3560523.
DOI: 10.12659/msm.881929.
Expression of Eph A molecules during swine embryo implantation.
Fu Y, Fu J, Ren Q, Chen X, Wang A
Mol Biol Rep. 2011; 39(3):2179-85.
PMID: 21656379
DOI: 10.1007/s11033-011-0966-0.
EphA4 expression promotes network activity and spine maturation in cortical neuronal cultures.
Clifford M, Kanwal J, Dzakpasu R, Donoghue M
Neural Dev. 2011; 6:21.
PMID: 21542907
PMC: 3100241.
DOI: 10.1186/1749-8104-6-21.
Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation.
Giorgio C, Hassan Mohamed I, Flammini L, Barocelli E, Incerti M, Lodola A
PLoS One. 2011; 6(3):e18128.
PMID: 21479221
PMC: 3068151.
DOI: 10.1371/journal.pone.0018128.
Emerging strategies for EphA2 receptor targeting for cancer therapeutics.
Tandon M, Vemula S, Mittal S
Expert Opin Ther Targets. 2010; 15(1):31-51.
PMID: 21142802
PMC: 3016619.
DOI: 10.1517/14728222.2011.538682.